Nabriva Therapeutics PLC
(OTCPK:NBRVF)
$
0.0001
0 (0%)
Market Cap: -
Enterprise Value: -
PE Ratio: 0
PB Ratio: 0
GF Score: 0/100 Nabriva Therapeutics PLC (NBRVF) Transcripts
- Q3 2022 Nabriva Therapeutics PLC Earnings Call TranscriptNov 10, 2022$2.18 (+3.32%)Earnings
- Q2 2022 Nabriva Therapeutics PLC Earnings Call TranscriptAug 03, 2022$4.93 (+8.72%)Earnings
- Q1 2022 Nabriva Therapeutics PLC Earnings Call TranscriptMay 05, 2022$7.25 (-5.01%)Earnings
- Q4 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMar 29, 2022$12.34 (+4.38%)Earnings
- Q3 2021 Nabriva Therapeutics PLC Earnings Call TranscriptNov 09, 2021$33.5 (+3.08%)Earnings
- Q2 2021 Nabriva Therapeutics PLC Earnings Call TranscriptAug 05, 2021$29 (-4.13%)Earnings
- Q1 2021 Nabriva Therapeutics PLC Earnings Call TranscriptMay 06, 2021$37.25 (-6.88%)Earnings
- Q4 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMar 11, 2021$45.75 (+4.57%)Earnings
- Q3 2020 Nabriva Therapeutics PLC Earnings Call TranscriptNov 05, 2020$122.05 (+3.87%)Earnings
- Q2 2020 Nabriva Therapeutics PLC Earnings Call TranscriptAug 06, 2020$202.5 (-1.89%)Earnings
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Nabriva Therapeutics PLC Earnings Call TranscriptMay 11, 2020$182.5 (+19.77%)Earnings
- Q4 2019 Nabriva Therapeutics PLC Earnings Call TranscriptMar 12, 2020$255 (-15.70%)Earnings
- Q3 2019 Nabriva Therapeutics PLC Earnings Call TranscriptNov 12, 2019$495 (-1.00%)Earnings
- Nabriva Therapeutics PLC at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Nabriva Therapeutics plc - Special Call TranscriptAug 19, 2019
- Nabriva Therapeutics PLC at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Nabriva Therapeutics plc Complete Response Letter from FDA on NDA Conference Call TranscriptMay 01, 2019
- 1